Takeda's diabetes drug may not involve heart risk

07/11/2007 | Bloomberg

Study results expected soon may show Takeda Pharmaceutical's drug Actos does not have the heart-attack risk claimed for GlaxoSmithKline's Avandia. One study indicates Actos protects against blood clots that cause heart attacks, and a pending review of past studies may confirm the finding, a Takeda official said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC